Merck (MRK) Reports Positive Top-line Results from Pivotal Phase 3 STELLAR Trial of Sotatercept

FREE Breaking News Alerts from StreetInsider.com!

E-mail Address

StreetInsider.com Top Tickers, 9/8/2026

1. SPY
2. USO
3. IONQ
4. IONS
5. ROIV
6. AAPL
7. ACN
8. AZN
9. ORCL
10. HOOD

Go back to Merck (MRK) Reports Positive Top-line Results from Pivotal Phase 3 STELLAR Trial of Sotatercept
Merck & Co. (NYSE: MRK) Delayed: 149.11 -1.22 (0.81%)
Previous Close $150.33    52 Week High $65.46 
Open $148.41    52 Week Low $47.97 
Day High $149.60    P/E 101.44 
Day Low $146.28    EPS $1.47 
Volume 4,068,365